Trial of a Health Promoting School Approach to Positive Youth Development and Wellness Promotion
NCT ID: NCT02840383
Last Updated: 2023-02-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
811 participants
INTERVENTIONAL
2017-09-05
2022-11-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Co-Creating Active Middle School Communities to Increase Student Physical Activity
NCT06970067
Social Mechanisms for Promoting Physical Activity in After School Programs for Underserved Middle School Youth
NCT03850821
Classroom Activities
NCT03394846
Neighborhood Park Youth Sports Program Fee Waiver and Intensive Family Outreach
NCT05231837
The CHAMP ASP: Promoting Physical Activity & Health in Children
NCT05342701
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim 1: Assess the effects of a school-based multi-component intervention on school connectedness, school engagement, and developmental assets through a group randomized, participatory trial.
Hypothesis 1a: Students in the intervention schools will experience improved school connectedness, engagement and developmental assets compared to the control group.
Aim 2: Assess the effects of a school-based multi-component intervention on emotional well-being, tobacco and other substance use, and academic outcomes through a group randomized, participatory trial.
Hypothesis 2a: Students in the intervention schools will experience improved emotional well-being, course completion, attendance, and decreased disciplinary action and substance use compared to the control group.
Aim 3: Evaluate the relationships between participatory factors , school intervention implementation, and study outcomes.
Exploratory hypothesis 3a: Perceptions of quality of collaborative processes will be associated with degree of school intervention implementation and study outcomes.
Exploratory hypothesis 3b: School capacities and context will be associated with school intervention implementation and study outcomes.
Exploratory hypothesis 3c: School capacities and context will mediate the relationship between quality of collaborative processes and school intervention implementation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Delayed Intervention
Schools not receiving intervention until two years after implementation.
Delayed Intervention
Schools not receiving intervention until two years after implementation.
Intervention
Schools receiving intervention at the beginning of study.
Intervention
intervention at the beginning of study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delayed Intervention
Schools not receiving intervention until two years after implementation.
Intervention
intervention at the beginning of study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* enrolled in the school at the time of randomization
Exclusion Criteria
14 Years
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Minority Health and Health Disparities (NIMHD)
NIH
SoLaHmo
UNKNOWN
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michele Allen, MD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota, Department of Family Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1601S82061
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.